What is Cerebrolysin? An In-Depth Look at Brain Repair and Neuroprotective Mechanisms

With advances in medical technology, treatment strategies for central nervous system (CNS) diseases have shifted from simple symptom management to promoting self-repair and neuroprotection. Among various neurorestorative medications, Cerebrolysin has drawn significant clinical interest for acute and chronic neurological conditions due to its unique multimodal mechanism of action.

1. What is Cerebrolysin?

Cerebrolysin is a multimodal biologic drug composed of low-molecular-weight peptides and free amino acids. It is derived from strictly purified porcine brain proteins. Cerebrolysin is also registered in Hong Kong.

Because of its extremely small peptide structure, Cerebrolysin can cross the blood-brain barrier (BBB) to act directly within the central nervous system. It mimics naturally occurring neurotrophic factors in the brain, providing essential nutrients and repair signals to damaged nerve cells.

2. What Does Cerebrolysin Do? (Key Benefits)

Cerebrolysin plays multiple roles in repairing the nervous system, with core benefits including:

• Promoting Neuroplasticity and Regeneration: Stimulates axonal growth and synapse formation, encouraging neural network reorganization.
• Neuroprotection: Shields neurons from cell death caused by ischemia, hypoxia, free radical attack (oxidative stress), and excitotoxicity.
• Improving Cognitive and Motor Function: Helps stroke or brain injury patients accelerate rehabilitation, enhancing memory performance and daily independence.
• Reducing Secondary Damage: Effectively mitigates tissue inflammation and secondary neurodegeneration following acute brain injury.

3. How Does Cerebrolysin Work? (Mechanism of Action)

When the brain suffers damage from ischemia, impact, or degeneration, natural neurotrophic factors drop significantly. Cerebrolysin promotes brain repair primarily by regulating two crucial cellular signaling pathways:

1. Neurotrophic Factor Pathway: Cerebrolysin acts similarly to brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). It maintains the integrity of neural networks, prevents damaged cells from undergoing apoptosis, and stimulates compensatory functions in remaining healthy neurons.
2. Sonic Hedgehog (Shh) Signaling Pathway: This pathway is vital for regulating neural stem cell proliferation, differentiation, and structural reorganization of brain tissue, supporting angiogenesis and structural rebuilding in damaged areas.

In short, Cerebrolysin suppresses inflammation and toxic cascades during the acute phase, while stimulating neural regeneration and network reorganization during the recovery phase.

4. What Conditions is Cerebrolysin Suitable For?

Clinical research and application show that Cerebrolysin is suitable for a range of acute and chronic CNS disorders:

• Ischemic and Hemorrhagic Stroke: Used in acute and rehabilitation phases, it accelerates motor function recovery in upper and lower limbs and reduces the risk of hemorrhagic transformation.
• Traumatic Brain Injury (TBI): Administered to patients with moderate-to-severe TBI, it improves cognitive domains like attention and memory while alleviating post-injury depressive symptoms.
• Alzheimer’s Disease: Used alone or in combination with acetylcholinesterase inhibitors (such as Donepezil) to improve cognitive performance and activities of daily living.
• Vascular Dementia: For cognitive decline caused by micro-strokes or cerebrovascular pathology, it significantly improves thinking and memory scores.

5. Is Cerebrolysin Safe? (Safety & Side Effects)

Based on clinical data from regulatory analyses such as the European Medicines Agency (EMA), Cerebrolysin is categorized as a prescription medication with a favorable safety profile and high tolerability.

• Common Mild Reactions: Some patients may experience a transient sensation of heat, mild dizziness, or palpitations during infusion. This is typically related to rapid administration and subsides when the infusion rate is slowed.
• Clinical Tolerability: Multiple large-scale, double-blind controlled trials in stroke and dementia demonstrate that adverse event rates in the Cerebrolysin group do not significantly differ from placebo.

Note: Cerebrolysin is a prescription-only medication. Specific dosages and treatment schedules (e.g., intravenous drip or intramuscular injection) must be evaluated and administered by a qualified healthcare professional based on individual medical conditions.

Summary

By mimicking the brain’s natural neurotrophic factors, Cerebrolysin offers an effective pathway to promote neural repair and functional recovery for patients recovering from stroke, brain injury, or dementia. For individuals seeking to improve cognitive function and accelerate motor recovery, it serves as a valuable adjunctive option in neurological rehabilitation.

References

1. Guekht, A. B., et al. (2011). Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial. Journal of Stroke and Cerebrovascular Diseases, 20(4), 310–318.
2. Alvarez, X. A., et al. (2015). Cerebrolysin in mild-to-moderate Alzheimer’s disease: a meta-analysis of randomized controlled clinical trials. Dementia and Geriatric Cognitive Disorders, 38(3-4), 173–186.
3. Muresanu, D. F., et al. (2016). Towards a multi-modal concept in stroke rehabilitation: Cerebrolysin in post-stroke recovery. Expert Review of Neurotherapeutics, 16(8), 921–932.
4. Vester, J. C., et al. (2020). Cerebrolysin after Traumatic Brain Injury: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (CAPTAIN Series). Neurological Research and Practice, 2(1), 19.
5. Bornstein, N. M., et al. (2018). Neurorestoration after stroke: a review of the clinical evidence for Cerebrolysin. Journal of Neural Transmission, 125(3), 385–393.